Vaxart Long Term Investments vs Accounts Payable Analysis

VXRT Stock  USD 0.60  0.01  1.64%   
Vaxart financial indicator trend analysis is much more than just breaking down Vaxart Inc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vaxart Inc is a good investment. Please check the relationship between Vaxart Long Term Investments and its Accounts Payable accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Long Term Investments vs Accounts Payable

Long Term Investments vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vaxart Inc Long Term Investments account and Accounts Payable. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Vaxart's Long Term Investments and Accounts Payable is 0.42. Overlapping area represents the amount of variation of Long Term Investments that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Vaxart Inc, assuming nothing else is changed. The correlation between historical values of Vaxart's Long Term Investments and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Investments of Vaxart Inc are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Long Term Investments i.e., Vaxart's Long Term Investments and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.42
Relationship DirectionPositive 
Relationship StrengthWeak

Long Term Investments

Long Term Investments is an item on the asset side of Vaxart balance sheet that represents investments Vaxart Inc intends to hold for over a year. Vaxart Inc long term investments may include different instruments such as stocks, bonds, real estate and cash.

Accounts Payable

An accounting item on the balance sheet that represents Vaxart obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Vaxart Inc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Vaxart's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vaxart Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxart Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Enterprise Value is likely to gain to about 127.8 M in 2024, whereas Selling General Administrative is likely to drop slightly above 21.2 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses70.6M110.4M90.7M95.3M
Cost Of Revenue48.7M3.3M68.1M53.4M

Vaxart fundamental ratios Correlations

0.210.290.450.980.57-0.64-0.530.820.680.390.9-0.10.70.42-0.180.80.730.650.480.850.270.090.04-0.57-0.41
0.21-0.070.010.10.60.35-0.69-0.170.470.52-0.01-0.420.610.460.030.40.610.450.58-0.110.56-0.07-0.2-0.44-0.35
0.29-0.070.790.30.06-0.240.020.260.07-0.140.230.620.03-0.3-0.110.040.10.130.020.29-0.04-0.25-0.24-0.080.04
0.450.010.790.430.37-0.19-0.20.280.310.060.280.620.28-0.24-0.140.320.230.30.270.330.14-0.20.22-0.31-0.23
0.980.10.30.430.47-0.73-0.370.870.610.320.93-0.010.60.26-0.150.740.60.480.40.910.110.070.12-0.54-0.36
0.570.60.060.370.470.16-0.850.090.90.820.26-0.310.920.490.210.720.850.680.870.190.720.070.02-0.74-0.66
-0.640.35-0.24-0.19-0.730.16-0.13-0.950.00.28-0.88-0.130.0-0.040.34-0.24-0.09-0.140.12-0.910.34-0.01-0.10.01-0.13
-0.53-0.690.02-0.2-0.37-0.85-0.13-0.13-0.73-0.6-0.260.4-0.85-0.750.13-0.63-0.95-0.84-0.83-0.15-0.83-0.010.250.510.44
0.82-0.170.260.280.870.09-0.95-0.130.24-0.10.950.040.280.21-0.330.470.350.360.130.94-0.070.040.07-0.22-0.05
0.680.470.070.310.610.90.0-0.730.240.760.38-0.320.920.50.090.760.830.660.80.310.610.41-0.1-0.82-0.83
0.390.52-0.140.060.320.820.28-0.6-0.10.760.16-0.520.710.480.520.540.630.510.50.10.410.20.0-0.6-0.58
0.9-0.010.230.280.930.26-0.88-0.260.950.380.16-0.080.40.32-0.220.590.480.470.180.98-0.060.00.08-0.3-0.11
-0.1-0.420.620.62-0.01-0.31-0.130.40.04-0.32-0.52-0.08-0.41-0.77-0.25-0.33-0.41-0.43-0.250.05-0.34-0.390.240.270.3
0.70.610.030.280.60.920.0-0.850.280.920.710.4-0.410.580.050.810.920.720.890.290.780.25-0.11-0.81-0.75
0.420.46-0.3-0.240.260.49-0.04-0.750.210.50.480.32-0.770.58-0.090.460.750.860.420.180.560.28-0.41-0.26-0.27
-0.180.03-0.11-0.14-0.150.210.340.13-0.330.090.52-0.22-0.250.05-0.09-0.1-0.1-0.16-0.05-0.210.01-0.10.21-0.1-0.03
0.80.40.040.320.740.72-0.24-0.630.470.760.540.59-0.330.810.46-0.10.730.620.660.490.480.140.15-0.76-0.61
0.730.610.10.230.60.85-0.09-0.950.350.830.630.48-0.410.920.75-0.10.730.860.810.370.750.11-0.32-0.6-0.51
0.650.450.130.30.480.68-0.14-0.840.360.660.510.47-0.430.720.86-0.160.620.860.560.350.620.17-0.28-0.41-0.38
0.480.580.020.270.40.870.12-0.830.130.80.50.18-0.250.890.42-0.050.660.810.560.110.840.09-0.08-0.7-0.63
0.85-0.110.290.330.910.19-0.91-0.150.940.310.10.980.050.290.18-0.210.490.370.350.11-0.19-0.050.14-0.24-0.04
0.270.56-0.040.140.110.720.34-0.83-0.070.610.41-0.06-0.340.780.560.010.480.750.620.84-0.190.11-0.25-0.56-0.49
0.09-0.07-0.25-0.20.070.07-0.01-0.010.040.410.20.0-0.390.250.28-0.10.140.110.170.09-0.050.11-0.27-0.41-0.7
0.04-0.2-0.240.220.120.02-0.10.250.07-0.10.00.080.24-0.11-0.410.210.15-0.32-0.28-0.080.14-0.25-0.27-0.070.04
-0.57-0.44-0.08-0.31-0.54-0.740.010.51-0.22-0.82-0.6-0.30.27-0.81-0.26-0.1-0.76-0.6-0.41-0.7-0.24-0.56-0.41-0.070.82
-0.41-0.350.04-0.23-0.36-0.66-0.130.44-0.05-0.83-0.58-0.110.3-0.75-0.27-0.03-0.61-0.51-0.38-0.63-0.04-0.49-0.70.040.82
Click cells to compare fundamentals

Vaxart Account Relationship Matchups

Vaxart fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets37.0M152.6M221.2M153.8M91.8M150.6M
Short Long Term Debt Total2.3M7.2M13.0M21.7M26.5M29.3M
Other Current Liab2.9M7.6M5.9M8.2M5.6M9.8M
Total Current Liabilities9.2M11.8M10.8M17.9M13.7M17.6M
Total Stockholder Equity13.0M123.4M187.5M110.6M57.8M89.3M
Property Plant And Equipment Net2.2M8.3M19.8M41.3M36.6M27.5M
Net Debt(11.2M)(119.7M)(130.7M)(22.3M)(8.2M)(8.7M)
Retained Earnings(116.7M)(148.9M)(219.4M)(327.1M)(409.6M)(389.1M)
Cash13.5M126.9M143.7M44.0M34.8M52.2M
Non Current Assets Total19.4M24.1M52.0M54.4M46.3M40.4M
Non Currrent Assets Other141K372K890K3.6M926K879.7K
Cash And Short Term Investments13.5M126.9M166.5M93.7M39.7M61.2M
Net Receivables3.6M334K71K20K3.0M2.9M
Common Stock Shares Outstanding21.6M88.3M121.5M127.7M144.8M152.1M
Liabilities And Stockholders Equity37.0M152.6M221.2M153.8M91.8M150.6M
Non Current Liabilities Total14.9M17.4M22.9M25.3M20.3M27.5M
Other Current Assets453K2.4M5.2M3.7M2.8M4.7M
Other Stockholder Equity129.6M272.3M406.9M438.0M467.4M490.7M
Total Liab24.1M29.2M33.6M43.3M34.0M44.6M
Property Plant And Equipment Gross2.2M8.3M19.8M15.6M43.4M24.7M
Total Current Assets17.6M128.5M169.2M99.5M45.5M43.3M
Accumulated Other Comprehensive Income(1.6M)(459K)(74K)(299K)(1K)(1.1K)
Short Term Debt841K2.1M1.0M2.3M6.5M6.8M
Intangible Assets17.1M15.4M10.6M5.0M4.3M4.1M
Accounts Payable852K2.1M3.9M5.5M1.6M1.5M
Common Stock Total Equity714K4.8M11K13K11.7K11.1K
Common Stock714K5K11K13K15K14.3K
Current Deferred Revenue4.6M4.2M5.1M2M1.8M1.7M
Other Liab13.4M14.9M10.9M5.9M6.7M7.9M
Net Tangible Assets13.0M123.4M187.5M110.6M127.2M67.4M
Other Assets141K372K890K3.6M4.1M4.3M
Retained Earnings Total Equity(116.7M)(148.9M)(219.4M)(327.1M)(294.4M)(279.7M)
Capital Surpluse124.8M272.3M406.9M438.0M503.7M528.9M
Property Plant Equipment210K1.5M6.6M15.6M17.9M18.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Vaxart Stock Analysis

When running Vaxart's price analysis, check to measure Vaxart's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxart is operating at the current time. Most of Vaxart's value examination focuses on studying past and present price action to predict the probability of Vaxart's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxart's price. Additionally, you may evaluate how the addition of Vaxart to your portfolios can decrease your overall portfolio volatility.